Improving Outcomes for Patients With Epidermal Necrolysis-Reference-Cited by-同舟云学术

Improving Outcomes for Patients With Epidermal Necrolysis

Published:2020-12-01 Issue:12 Volume:156 Page:1289
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Micheletti Robert G.¹²,Noe Megan H.³

Affiliation:

1. Perelman School of Medicine, Department of Dermatology, Department of Medicine, University of Pennsylvania, Philadelphia

2. Images in Dermatology Editor, JAMA Dermatology

3. Department of Dermatology, Brigham and Women’s Hospital, Harvard University of School of Medicine, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/2771823/jamadermatology_micheletti_2020_ed_200017_1607046257.0633.pdf

Reference13 articles.

1. Trends in mortality rates for Stevens-Johnson syndrome and toxic epidermal necrolysis: experience of a single centre in France between 1997 and 2017.;Bettuzzi;Br J Dermatol,2020

2. Stevens-Johnson syndrome/toxic epidermal necrolysis: a multicenter retrospective study of 377 adult patients from the United States.;Micheletti;J Invest Dermatol,2018

3. Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.;Sekula;J Invest Dermatol,2013

4. Assessment and comparison of performance of ABCD-10 and SCORTEN in prognostication of epidermal necrolysis.;Koh;JAMA Dermatol

5. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis.;Bastuji-Garin;J Invest Dermatol,2000

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resolvin D3 controls mouse and human TRPV1-positive neurons and preclinical progression of psoriasis;Theranostics;2020